Economic evaluation of cardiac magnetic resonance with fast-SENC in the diagnosis and management of early heart failure

Table 1 Clinical Input Data for Payer Model

Variables	Base-case	Article References
Average age of cohort	64	[25]
Prevalence of HF stage B+ after Charlson screening	0.2	Pretest assumption
Outcomes discount rate	3%	[40]
SENC Rest Diagnostic Accuracy	1	[18]
4-year progression in prevalence of stage B	0.154	[41]
ECHO at rest
Stage C	4.27%	[42]
Stage C+	4.55%	[42]
Stage D	4.50%	[26]
Mortality	6.94%	[42]
Fast-SENC
Stage C	3.11%	[42]
Stage C+	3.32%	[42]
Stage D	3.28%	Assumption
Mortality	5.43%	[42]
Percent of Heart Failure Hospitalizations that are Preventable	54.20%	[16]
50% reduction in preventable hospitalization for SENC	27.10%	Assumption
HF hospitalization (annualized rate)	32.02%	[17]
30-day HF rehospitalization	26.90%	[43]

ISSN: 2191-1991